Table Of Contents:

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

  1.1.1 Why This Market Is Gaining Strategic Attention

  1.1.2 Business Decisions This Report Supports

 1.2 Scope

 1.3 Research & Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Component

  2.3.2 Market Size By Technology

  2.3.3 Market Size By Application

  2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Genomic Data, Biobank & Clinical Data Providers

  3.4.2 AI Software, Algorithm & Computing Hardware Developers

  3.4.3 Diagnostic Laboratories, Sequencing Service Providers & Integrators

  3.4.4 Healthcare Providers, Pharma & Biotech Companies and Research Institutes

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Genomic Data & Precision Medicine Foundation Metrics

  4.1.1 Genome Sequencing Volumes & Cost per Genome

  4.1.2 Genomic Test Volumes by Clinical Area

  4.1.3 Biobank & Population Genomics Initiatives

  4.1.4 Electronic Health Record & Multi-Omics Data Availability

 4.2 Disease Burden & Targeted Therapy Indicators

  4.2.1 Cancer Incidence & Biomarker-Driven Treatment Eligibility

  4.2.2 Companion Diagnostic & Targeted Therapy Approvals

  4.2.3 Rare Disease Diagnosis Rates & Time to Diagnosis

  4.2.4 Neurology, Cardiology & Respiratory Disease Burden

 4.3 AI Adoption & Clinical Validation Metrics

  4.3.1 AI-Enabled Diagnostic & Pathology Tool Approvals

  4.3.2 Clinical Validation & Performance Benchmarks

  4.3.3 Healthcare Provider AI Adoption Rates

  4.3.4 Pharma AI Use in Drug Discovery & Trial Design

 4.4 Regulatory, Data Privacy & Reimbursement Environment

  4.4.1 AI Medical Device Regulatory Frameworks

  4.4.2 Genomic Data Privacy & Governance Requirements

  4.4.3 Reimbursement Policies for Genomic & AI-Based Testing

  4.4.4 Ethical AI & Algorithm Transparency Standards

 4.5 Investment, Infrastructure & Technology Trends

  4.5.1 Venture & Strategic Investment in Precision Medicine AI

  4.5.2 Cloud & High-Performance Computing Infrastructure

  4.5.3 Foundation Models & Generative AI in Biomedicine

  4.5.4 Partnerships Between Technology, Pharma & Healthcare Providers

5. AI in Precision Medicine Market Segmental Analysis & Forecast, By Component, 2022–2035, Value (USD Billion)

 5.1 Introduction

 5.2 Software

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Services

 5.4 Hardware

6. AI in Precision Medicine Market Segmental Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

 6.1 Introduction

 6.2 Deep Learning

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Machine Learning

 6.4 Natural Language Processing

 6.5 Others

7. AI in Precision Medicine Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

 7.1 Introduction

 7.2 Oncology

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Neurology

 7.4 Cardiology

 7.5 Respiratory

 7.6 Others

8. AI in Precision Medicine Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

 8.1 Introduction

 8.2 Healthcare Providers

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Pharma & Biotech

 8.4 Academic & Research Institutes

 8.5 Others

9. AI in Precision Medicine Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

 9.1 Introduction

 9.2 North America

  9.2.1 Key Trends

  9.2.2 AI in Precision Medicine Market Size & Forecast, By Component, 2022–2035

  9.2.3 AI in Precision Medicine Market Size & Forecast, By Technology, 2022–2035

  9.2.4 AI in Precision Medicine Market Size & Forecast, By Application, 2022–2035

  9.2.5 AI in Precision Medicine Market Size & Forecast, By End User, 2022–2035

  9.2.6 AI in Precision Medicine Market Size & Forecast, By Country, 2022–2035

   9.2.6.1 USA

   9.2.6.2 Canada

 9.3 Europe

  9.3.1 Key Trends

  9.3.2 AI in Precision Medicine Market Size & Forecast, By Component, 2022–2035

  9.3.3 AI in Precision Medicine Market Size & Forecast, By Technology, 2022–2035

  9.3.4 AI in Precision Medicine Market Size & Forecast, By Application, 2022–2035

  9.3.5 AI in Precision Medicine Market Size & Forecast, By End User, 2022–2035

  9.3.6 AI in Precision Medicine Market Size & Forecast, By Country, 2022–2035

   9.3.6.1 Germany

   9.3.6.2 UK

   9.3.6.3 France

   9.3.6.4 Italy

   9.3.6.5 Spain

   9.3.6.6 Russia

   9.3.6.7 Poland

   9.3.6.8 Rest of Europe

 9.4 Asia-Pacific

  9.4.1 Key Trends

  9.4.2 AI in Precision Medicine Market Size & Forecast, By Component, 2022–2035

  9.4.3 AI in Precision Medicine Market Size & Forecast, By Technology, 2022–2035

  9.4.4 AI in Precision Medicine Market Size & Forecast, By Application, 2022–2035

  9.4.5 AI in Precision Medicine Market Size & Forecast, By End User, 2022–2035

  9.4.6 AI in Precision Medicine Market Size & Forecast, By Country, 2022–2035

   9.4.6.1 China

   9.4.6.2 India

   9.4.6.3 Japan

   9.4.6.4 South Korea

   9.4.6.5 Australia

   9.4.6.6 ASEAN Countries

   9.4.6.7 Rest of Asia-Pacific

 9.5 Latin America

  9.5.1 Key Trends

  9.5.2 AI in Precision Medicine Market Size & Forecast, By Component, 2022–2035

  9.5.3 AI in Precision Medicine Market Size & Forecast, By Technology, 2022–2035

  9.5.4 AI in Precision Medicine Market Size & Forecast, By Application, 2022–2035

  9.5.5 AI in Precision Medicine Market Size & Forecast, By End User, 2022–2035

  9.5.6 AI in Precision Medicine Market Size & Forecast, By Country, 2022–2035

   9.5.6.1 Brazil

   9.5.6.2 Argentina

   9.5.6.3 Mexico

   9.5.6.4 Colombia

   9.5.6.5 Rest of Latin America

 9.6 Middle East & Africa

  9.6.1 Key Trends

  9.6.2 AI in Precision Medicine Market Size & Forecast, By Component, 2022–2035

  9.6.3 AI in Precision Medicine Market Size & Forecast, By Technology, 2022–2035

  9.6.4 AI in Precision Medicine Market Size & Forecast, By Application, 2022–2035

  9.6.5 AI in Precision Medicine Market Size & Forecast, By End User, 2022–2035

  9.6.6 AI in Precision Medicine Market Size & Forecast, By Country, 2022–2035

   9.6.6.1 UAE

   9.6.6.2 Saudi Arabia

   9.6.6.3 Qatar

   9.6.6.4 South Africa

   9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Year-Wise Strategies & Development, 2022–2026

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

 10.6 Key Company Profiles

  10.6.1 Tempus AI, Inc.

   10.6.1.1 Company Overview & Snapshot

   10.6.1.2 Product/Service Portfolio

   10.6.1.3 Key Company Financials

   10.6.1.4 Geographical Presence

   10.6.1.5 SWOT Analysis

  10.6.2 Illumina, Inc.

  10.6.3 SOPHiA GENETICS SA

  10.6.4 Caris Life Sciences, Inc.

  10.6.5 Owkin

  10.6.6 PathAI, Inc.

  10.6.7 Lunit Inc.

  10.6.8 Freenome Holdings, Inc.

  10.6.9 GeneDx Holdings Corp.

  10.6.10 QIAGEN N.V.

  10.6.11 DNAnexus, Inc.

  10.6.12 F. Hoffmann-La Roche Ltd

  10.6.13 Ibex Medical Analytics

  10.6.14 NVIDIA Corporation

  10.6.15 Google DeepMind

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions On Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures